ACR 160 is a nonbinding legislative resolution that proclaims April 2026 as Parkinson’s Disease Awareness Month in California. The resolution uses extensive findings to describe Parkinson’s disease as a fast-growing, progressive neurological disorder, outline its symptoms and public health burden, and highlight the need for research, early detection, caregiver support, and improved treatment options. It also references the role of California’s research institutions, health systems, and disease registries in advancing understanding of neurodegenerative disease.
The measure does not create a new regulatory program, mandate spending, or change substantive health or insurance law. Its legal effect is to formally designate an awareness month and direct the Chief Clerk to transmit copies of the resolution for distribution. The resolution also situates Parkinson’s disease within broader state public health and research efforts, including the California Parkinson’s Disease Registry, the California Neurodegenerative Disease Registry, and ongoing review of pesticide exposure and neurological health.
Impact
ACR 160 primarily affects state ceremonial and commemorative law by officially recognizing April 2026 as Parkinson’s Disease Awareness Month. It does not amend the Health and Safety Code, impose duties on agencies, or alter benefits, licensing, or treatment requirements. Its practical impact is symbolic and educational, but the findings may help reinforce public awareness of Parkinson’s disease, support for caregivers and patients, and the importance of continued research and data collection in California.
Sentiment
The sentiment around the bill appears strongly supportive and unanimous. The vote history shows no opposition in either chamber, including a 7-0 committee vote and a 36-0 floor vote under special consent. The resolution’s findings are framed in a sympathetic, public-health-oriented way, emphasizing the burden on patients, families, researchers, and health systems, and there is no indication of controversy in the available discussion record.
Contention
There is little to no visible contention over the resolution itself because it is an awareness measure rather than a policy change. The only potentially sensitive policy references are the findings discussing environmental exposures, pesticide regulation, and paraquat reevaluation, but those references are informational and do not direct new regulatory action in this resolution. Any broader debate would likely relate to pesticide policy or environmental causes of Parkinson’s disease, not to the month designation itself.